Which oral angiotensin‑converting enzyme inhibitor or angiotensin receptor blocker combined with a calcium‑channel blocker is appropriate for an adult with hypertensive urgency?

Oral ACE Inhibitor/ARB + CCB for Hypertensive Urgency

For hypertensive urgency (BP >180/120 mmHg without acute target organ damage), use oral captopril 25 mg or enalapril 5-10 mg combined with oral amlodipine 5-10 mg, with reassessment in 30-60 minutes and outpatient follow-up within 24-72 hours.

Key Distinction: Urgency vs Emergency

Hypertensive urgency means severely elevated BP (>180/120 mmHg) WITHOUT acute target organ damage. These patients do NOT require IV medications or ICU admission 1, 2, 3. In contrast, hypertensive emergencies involve acute target organ damage (encephalopathy, stroke, MI, pulmonary edema, aortic dissection) and require immediate IV therapy in an ICU setting 1, 2.

Recommended Oral Combination Approach

First-Line Agents:

ACE Inhibitor Options:

• Captopril 25 mg (onset 15-30 minutes, can repeat in 1 hour if needed) 4
• Enalapril 5-10 mg (onset 30-60 minutes) 4

Combined with CCB:

• Amlodipine 5-10 mg (long-acting dihydropyridine) 5, 6

Alternative ARB Options:

• Losartan 25-50 mg 4
• Irbesartan 150 mg 4

Rationale for This Combination:

The combination of RAS blocker (ACE inhibitor or ARB) with a dihydropyridine CCB is explicitly recommended as a preferred combination across multiple major guidelines 7, 5, 6. This pairing:

• Targets complementary pathways (RAS blockade + direct vasodilation)
• Reduces peripheral edema risk from CCB monotherapy 7
• Provides sustained BP control over 24 hours
• Has proven cardiovascular outcome benefits 6, 8

Treatment Algorithm:

1. Confirm hypertensive urgency (not emergency): No chest pain, dyspnea, neurological deficits, or acute end-organ damage 3, 9

2. Administer oral combination:

   • Captopril 25 mg + Amlodipine 5-10 mg, OR
   • Enalapril 5-10 mg + Amlodipine 5-10 mg

3. Reassess BP in 30-60 minutes:

   • Target: Reduce BP by 20-25% in first hour, NOT to normal 1, 2
   • Avoid precipitous drops (risk of stroke/MI)

4. Disposition:

   • Discharge with oral antihypertensive regimen
   • Arrange outpatient follow-up within 24-72 hours 3
   • Educate on medication adherence (most urgencies result from non-compliance) 1

Critical Pitfalls to Avoid:

Do NOT use IV medications for urgency - No evidence supports this practice, and it increases risk of excessive BP reduction 10, 9. IV therapy is reserved for true emergencies with target organ damage 1, 2.

Avoid sublingual nifedipine - While historically used, rapid-acting short-acting CCBs cause unpredictable, precipitous BP drops and are not recommended 11.

Do NOT combine ACE inhibitor + ARB - This combination is explicitly contraindicated due to increased harm without additional benefit 7, 5, 12.

Target gradual reduction - Reducing BP to "normal" acutely can cause ischemic complications in patients with chronic hypertension who have shifted cerebral autoregulation curves 2, 9.

Long-Term Management:

Most patients with hypertensive urgency require two-drug combination therapy for sustained control 7, 5. The 2025 AHA/ACC guidelines strongly recommend initiating stage 2 hypertension (≥140/90 mmHg) with two first-line agents, ideally as a single-pill combination to improve adherence 7. The preferred combinations remain:

• ACE inhibitor or ARB + CCB
• ACE inhibitor or ARB + thiazide diuretic
• CCB + thiazide diuretic 7, 5, 6

The ESC 2024 guidelines emphasize that fixed-dose single-pill combinations are recommended over separate pills to enhance adherence 5.